SEC Filings TLDR

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for MGE Energy Inc., reporting a decrease in its ownership. As of September 30, 2025, BlackRock beneficially owns 5,616,238 shares of MGE Energy Inc.'s common stock, representing a 15.4% ownership stake. This reflects a decrease of 67,581 shares compared to t...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for Merit Medical Systems Inc., reflecting changes in its ownership as of September 30, 2025. BlackRock, Inc. now holds 8,370,301 shares of common stock, representing 14.1% ownership. This is a decrease of 344,906 shares from its previous filing, resulting in...

BlackRock, Inc. has filed an amendment to its Schedule 13G for Medical Properties Trust Inc., reporting ownership of 69,021,718 shares, representing 11.5% of the outstanding common stock. The filing indicates a decrease in shares owned by 12,996,548, or 15.8459%, compared to the previous report. The value of the shares...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing a reduction in its stake in Marriott Vacations Worldwide Corp. As of September 30, 2025, BlackRock owns 3,366,770 shares, representing 9.7% of the company's common stock. This marks a decrease of 753,715 shares (18.29%) from its previous hold...

BlackRock, Inc. has filed a Schedule 13G/A amendment, disclosing a reduction in its ownership of MarketAxess Holdings Inc. common stock. As of September 30, 2025, BlackRock holds 1,572,513 shares, representing a 4.2% ownership stake. This marks a significant decrease from its previous holdings, with a reduction of 1,07...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, reporting a 5.9% ownership in Maravai Lifesciences Holdings, Inc. as of September 30, 2025. The filing indicates that BlackRock beneficially owns 8,580,553 shares of common stock, with sole voting power over 8,375,467 shares and sole dispositive power o...

BlackRock, Inc. has filed a Schedule 13G/A amendment, disclosing an increased ownership in MACOM Technology Solutions Holdings Inc. As of September 30, 2025, BlackRock holds 6,742,929 shares, representing 9.1% of the company's common stock. This marks an increase of 904,946 shares from their previous filing, with the v...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for Luminar Technologies, Inc., reporting ownership of 2,820,740 shares, representing 4.4% of the outstanding common stock. The filing indicates that BlackRock has sole voting power over 2,764,789 shares and sole dispositive power over all 2,820,740 shares. T...

BlackRock, Inc. has filed a Schedule 13G/A amendment reporting a 4.9% ownership in Liberty Broadband Corp's Class A Stock. The filing indicates that BlackRock, Inc. beneficially owns 897,543 shares, with sole voting power over 856,938 shares and sole dispositive power over 897,543 shares. The filing also states that no...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A, disclosing an increase in its ownership of Lexeo Therapeutics, Inc. common stock. As of September 30, 2025, BlackRock owns 2,168,444 shares, representing 4.0% of the total outstanding shares. This marks a significant increase from its previous holdings, with...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for LKQ Corporation, reporting a decrease in its ownership. As of September 30, 2025, BlackRock owns 15,975,346 shares of LKQ Corporation's common stock, representing 6.2% of the total outstanding shares. This marks a decrease of 7,022,872 shares (30.54%) and...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for Ligand Pharmaceuticals Inc., reporting ownership of 2,839,251 shares, representing 14.5% of the common stock. The filing indicates that BlackRock has sole voting power over 2,792,360 shares and sole dispositive power over all 2,839,251 shares. The filing ...

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a reduction in its ownership stake in LifeCore Biomedical, Inc. As of September 30, 2025, BlackRock owns 1,834,319 shares, representing 4.9% of the outstanding common stock. This marks a decrease of 40,507 shares from its previous filing, with the v...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for Lattice Semiconductor Corporation, reporting ownership of 13,675,786 shares, which represents 10.0% of the company's common stock. The filing indicates that BlackRock, Inc. has sole voting power over 13,195,366 shares and sole dispositive power over all 1...

JPMorgan Chase & Co has filed an amendment to its Schedule 13G, disclosing an increased ownership of 4.9% in Karyopharm Therapeutics Inc. The filing, dated October 17, 2025, reveals that JPMorgan Chase & Co now holds 427,624 shares of Karyopharm's common stock, representing a 66.75% increase in shares and a 129.43% inc...

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing an increased ownership stake in Kratos Defense & Security Solutions, Inc. As of September 30, 2025, BlackRock beneficially owns 21,491,945 shares of Kratos common stock, representing 12.7% of the total outstanding shares. This marks an increa...

BlackRock Portfolio Management LLC has filed a Schedule 13G/A amendment with the SEC, disclosing its ownership of 5.1% of the common stock of Kinross Gold Corp. The filing indicates that BlackRock beneficially owns 65,808,274 shares, with sole voting power over 60,537,996 shares and sole dispositive power over all 65,8...

BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing an increased ownership in Jade Biosciences Inc. As of September 30, 2025, BlackRock owns 2,150,203 shares of common stock, representing a 6.6% ownership stake. This marks an increase of 435,855 shares from the previous filing, reflecting a 25.424% r...

JPMorgan Chase & Co. has filed an amendment to its Schedule 13G, reporting a 4.9% ownership in Karyopharm Therapeutics Inc. The filing indicates that JPMorgan Chase & Co. holds 427,624 shares of common stock, with sole voting and dispositive power over these shares. The filing also confirms that the securities were acq...

JPMorgan Chase & Co. has filed an amendment to its Schedule 13G for Fidelity National Information Services, Inc., reporting ownership of 44,621,625 shares, representing 8.5% of the common stock. The filing details the breakdown of voting and dispositive power, with JPMorgan Chase & Co. holding sole voting power over 39...

JPMorgan Chase & Co. has filed a Schedule 13G/A amendment with the SEC, reporting a 3.5% ownership in CI&T Inc. The filing indicates that JPMorgan Chase & Co. beneficially owns 800,105 Class A common shares of CI&T Inc. The shares are held in the ordinary course of business and not for the purpose of influencing the co...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for JetBlue Airways Corp, reporting ownership of 42,892,176 shares, which represents 11.8% of the company's common stock. The filing indicates that BlackRock has sole voting power over 42,247,454 shares and sole dispositive power over all 42,892,176 shares. T...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A for J&J Snack Foods Corp, reporting a decrease in its ownership. As of September 30, 2025, BlackRock owns 2,188,306 shares, representing 11.2% of the outstanding common stock. This marks a decrease of 91,534 shares from the previous filing, reflecting a 4.01%...

BlackRock, Inc. has filed an amendment (Schedule 13G/A) to report a reduction in its stake in Interactive Brokers Group Inc. As of September 30, 2025, BlackRock owns 27,619,620 shares of Class A Stock, representing a 6.2% ownership stake. This marks a decrease of 12,617,108 shares (31.36%) from its previous holdings. T...

BlackRock, Inc. has filed an amendment to its Schedule 13G/A, reporting a reduction in its ownership of Inspire Medical Systems Inc. (INSP) common stock. As of September 30, 2025, BlackRock owns 3,353,407 shares, representing 11.3% of the outstanding common stock. This marks a decrease of 520,379 shares (13.43%) from i...